Tci Co., Ltd.

Cheng-Yu Ho

Yung-Hsiang Lin

Chu-Han Huang

Jin-Jia Wang

Po-Chun Hsu

Huan-You Lin

The present disclosure provides a method for regulating expression of IL-1&#x3b2; gene, MMP1a gene and TIMP1 gene of chondrocytes using astrain TCI227.

Method for reducing inflammation of chondrocytes caused by uric acid crystals usingTCI227

Provided is a method of promoting the growth of, including contactingwith an effective amount of a prebiotic composition including aferment. Also provided is a prebiotic composition including aferment. The prebiotic composition promotes the growth ofin the intestine, and reduces the body weight, fat percentage, waist circumference, and hip circumference of obese individuals.

Method for promoting growth ofusingferments

Provided is a method of improving urogenital health, including administering to a subject a composition including an effective amount of astrain deposited under the accession number of DSM 33288 or a metabolite thereof. Thestrain, which is a probiotic, and metabolites thereof inhibit the growth of common pathogenic bacteria and fungi causing genitourinary tract infections, thereby reducing the risk of genitourinary tract infections or alleviating symptoms thereof. Also provided is a composition for improving urogenital health which includes thestrain.

Method of improving urogenital health using probiotic bacteria

Dow02-2 is provided, wherein theDow02-2 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen and Zellkulturen, DSMZ) under the accession number DSM33380, and its metabolites comprise 2-hydroxy-3-methylbutyric acid. A method for providing 2-hydroxy-3-methylbutyric acid is also provided, wherein the method comprises isolating the 2-hydroxy-3-methylbutyric acid from metabolites ofDow02-2 of biologically pure culture. A method for at least one of increasing expression of TGM1 gene, increasing expression of KRT1 gene, increasing expression of KRT10 gene, increasing expression of KRT14 gene, increasing expression of FLG gene, increasing expression of GBA gene, and increasing expression of HAS3 gene is also provided, wherein the method comprises administering to a subject in need thereof an effective amount of 2-hydroxy-3-methylbutyric acid.

Alteromonas macleodii Dow02-2 and its metabolites for improving skin moisturization

TCI378 is provided. TheTCI378 was deposited at German Collection of Microorganisms and Cell Cultures (Deutsche Sammlung von Mikroorganismen and Zellkulturen, DSMZ) under the accession number DSM 32451. A method for losing fat and/or improving gastrointestinal functions is also provided. The method comprises administering to a subject in need an effective amount of a composition, wherein the composition comprisesTCI378 and/or its metabolites.

TCI378 and its uses in losing fat and improving gastrointestinal functions

The present invention provides a method of reducing body fat, comprising administering a composition comprising an effective amount ofor a metabolite thereof to a subject in need thereof. Theor the metabolite thereof can effectively convert the fatty acid into conjugated linoleic acid, inhibit the accumulation of fat and promote the decomposition of fat in fat cells, and can effectively reduce the percentage of body fat, waist circumference, and hip circumference, and simultaneously increase the muscle mass of the subject.

Reducing body fat probiotic strain, composition thereof, and use thereof

A live bacteria-containing particulate is provided, wherein the particulate comprises a bacterial strain, a first covering layer, and a second covering layer, and wherein the first covering layer is in-between the cell membrane and cell wall of the bacterial strain and the bacterial strain is dispersed in the second covering layer. A method of preparing a live bacteria-containing particulates is also provided, wherein the method comprises the following steps: (a) subjecting a bacterial strain to a three-stage fermentation to obtain a fermentation broth; (b) concentrating the fermentation broth to provide a concentrated bacterial solution; (c) mixing the concentrated bacterial solution with a protective agent; and (d) drying the mixture to provide live bacteria-containing particulates.

Particulate structure with a high concentration of live bacteria and method of preparing the same

The present invention provides a banana fermentation product, which is obtained by subjecting a banana pulp juice to a pre-fermentation and then a post-fermentation, wherein the pre-fermentation is conducted in the presence ofand yeast and the post-fermentation is conducted in the presence of. The banana fermentation product of the present invention is effective in anti-oxidation, increasing the amount of probiotics in the intestinal tract, reducing the amount of bad bacteria in the intestinal tract, and relieving constipation symptoms. The banana fermentation product of the present invention can further be used for providing an edible composition or a pharmaceutical composition.

Banana fermentation product and manufacturing method and use of the same

A bio cellulose membrane with an outstanding water retention capacity and a method for producing the same are provided. The bio cellulose membrane comprises a first surface, a second surface, and a loose layer, wherein the average pore size of the first surface and the average pore size of the second surface are smaller than that of the loose layer.

Growing community of inventors

Taipei, Taiwan

Cheng-Yu Ho